STUDresearch · Non-peptide
Nattokinase
Also known as
NSK-SD · NK · nattokinase 2000 FU · nattokinase 10800 · fermented soybean enzyme · natto extract
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Systemic oral serine protease from natto.
One multi-year user described a rough first week, split 4,000 FU uses across the day, worsening during a five-day stop and return to baseline after restarting. The same author used one meal a day, followed a mostly carnivore/keto diet credited as helping about as much, and later remained exercise-limited despite greater function.
Common bottle and community amount; not a prescription or proof of an individual response.
Forum and reference-summary range; benefits, null effects, light-headedness and worsening all appear in inspected discussions.
The plaque claimant also used fish oil, atorvastatin and HMB 4,000 mg, exercised two or three times weekly, changed diet and drank little alcohol, then later noticed slower bleeding. Those co-interventions and the lack of a controlled comparator prevent a causal plaque claim.
Half-life & effect duration
- Half-life in the body
- Intact oral enzymeNo settled estimate
- Felt duration people report
- Some accountsNothing noticeable
- Other accountsChanges over days or months, with relapse after stopping in some
- Adverse reportsLight-headedness, symptom flares or bleeding-related concerns
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
A terminal half-life for intact, active oral nattokinase is not established by the reviewed human pilot.
Ero et al. observed ELISA binding above baseline from 2 to 24 hours with a peak around 13.3 ± 2.5 hours after 2,000 FU, but the assay used a polyclonal antibody and the authors called for studies separating intact enzyme and bioactive peptides.
Eleven-person single-dose pilot; antibody binding may include metabolites, activity was not established for the detected material, and Tmax is not half-life.
- A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose (opens in a new tab)Abstract: 11 healthy adults swallowed one 2,000 FU NSK-SD softgel; ELISA sampling at 2, 4, 8, 12, 24 and 48 hours found peak binding at about 13.3 ± 2.5 hours and significant elevation from 2 through 24 hours.Small uncontrolled pilot; the polyclonal antibody could detect intact nattokinase and/or metabolites, so the study does not establish active parent identity or terminal elimination half-life.
Felt duration people report
No usual felt duration emerges: many feel nothing, while others describe changes over days or months, relapse after stopping, light-headedness, symptom flares or bleeding-related concerns.
One long-term user described a rough first week, 10,000–12,000 FU/day around a five-day stop/restart and later 8,000 FU/day while still exercise-limited, alongside major diet and fasting changes. A separate plaque claimant recalculated an initially rounded 10,800 FU/day as 10,668 FU/day while also using fish oil, atorvastatin and HMB and changing exercise, diet and alcohol; other participants described no effect, worsening, an unconfirmed hematoma or possible blood-pressure effects.
Severely confounded illness cohorts, variable products, OMAD/carnivore-keto diet, fish oil, atorvastatin, HMB, exercise and other co-treatments, no blinded rechallenge or objective clot measure, and adverse events were not clinically adjudicated in-thread.
- Nattokinase experience — long-COVID stop/restart report and conflicting replies (opens in a new tab)Original account and same-author replies: several years near 10,000 FU/day; a rough first week; split 4,000 FU uses on waking, at lunch and after work during a 10,000–12,000 FU/day phase; worsening during a five-day stop and return to baseline after restarting; later 8,000 FU/day with greater function but continued gym/exercise setbacks. Visible replies also included worse symptoms, no benefit and an unconfirmed spontaneous hematoma after two months.Uncontrolled self-reports in heterogeneous long-COVID illness, variable brands and co-treatments; the lead author used one meal a day, followed a mostly carnivore/keto diet and credited diet as helping about as much as nattokinase. No product assay, imaging or clinical causality assessment was supplied.
- Nattokinase? Whose is still taking it — long-duration community thread (opens in a new tab)Visible thread contains 4,000 FU and higher reports ranging from no obvious impact after months to claimed symptom or blood-pressure benefit. One plaque claimant initially described about 10,800 FU/day, later recalculated it as 10,668 FU/day, and disclosed fish oil, atorvastatin, HMB 4,000 mg, exercise two or three times weekly, diet changes and little alcohol before later noticing slower bleeding.Cross-sectional anonymous discussion with changing regimens, fish oil, atorvastatin, HMB, exercise, diet and alcohol co-intervention confounding, uncertain units in some comments and no verified laboratory or imaging records; plaque causality and the slower-bleeding report were not clinically established.
Other context in this card
- A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles (opens in a new tab)Randomized double-blind placebo-controlled crossover in 12 healthy young men: one 2,000 FU oral dose, with coagulation and fibrinolysis markers sampled at 2, 4, 6 and 8 hours; changes remained within normal ranges.Small acute biomarker study; pharmacodynamic marker timing does not establish intact enzyme half-life, felt duration, plaque regression or clinical event prevention.
What people say
- r/Supplements: 2,000 FU Nutricost × 5 days — one user said BP dropped so low they could not stand. Others say 2,000 does nothing and they run 8–12k. anecdote
- Long-COVID boards: 4,000–8,000 FU (sometimes with lumbrokinase) for “microclot” lore. Thin evidence, real bleeding anxiety. forum
- Varicose / circulation feel: A minority of supplement threads claim less ache. Confounded. forum
- BP: Occasional drop reports — treat as a watch-for, not a hypertension drug. forum
- 2,000 FU single-dose labs: NSK-SD raised fibrin-degradation markers vs baseline in small studies — the “it does something to fibrin” citation. trial
- High-dose plaque talk: Chen-style 10,800 FU/day × 12 months → smaller carotid plaque / CIMT in a large uncontrolled series. Loud, and loudly criticized (no control, co-interventions). trial
Doses people talk about
- Classic supplement: 2,000 FU once daily (often empty-stomach lore). forum
- High-dose internet: 10,800–12,000 FU/day (Chen paper / CoffeeBlack 12,000 FU). forum
- Empty stomach vs with food: Empty-stomach is the copied instruction so stomach acid “doesn’t kill it.” Evidence for that ritual is thin. forum
- Not milligrams. Compare FU to FU. forum
- Middle: 4,000–7,000 FU/day — WebMD’s “most often used” band. trial
- Framing: FU on the bottle, not a prescription. forum
How it may feel
- Days 1–7: Most feel nothing. Easy-bruise and nosebleed stories start here if they are going to. forum
- Weeks 2–8: BP-drop n=1s and “I think my legs ache less.” Labs (D-dimer, etc.) are what the careful logs actually chase. forum
- Months 6–12: The plaque-paper window. YouTube “I stopped nattokinase” videos argue the 36% plaque claim is marketing. forum
- Stop: No receptor withdrawal. Bruising risk is framed as on-drug. forum
Cycles people discuss
- Daily open-ended: Cardio-biohack pattern is months, not 8-week blasts. forum
- DrMAWZ 90-day n=1: A defined experiment window. forum
- Not a statin cycle. Different job. forum
- Stop ≥2 weeks before surgery is the WebMD-style caution people repeat. trial
Timing
- Enzyme, not a 17-hour PDE5. Activity talk is hours; people still dose once daily. forum
- Empty-stomach morning is the ritual. forum
- With blood thinners: Additive bleeding risk — the hard interaction. trial
More on what it is
- Why people talk about it: 2025–26 cardio-biohack and long-COVID rooms. CoffeeBlackMD’s 12,000 FU daily stack and DrMAWZ’s 90-day n=1 put it on this map’s radar. forum
- Not vitamin K2 / not natto food. The enzyme is isolated; vitamin K in whole natto is a different clotting story. forum
- What it is: A 275-amino-acid enzyme from fermented soy (Bacillus subtilis natto). Dosed in fibrinolytic units (FU), not milligrams. NSK-SD is the branded extract people name. trial
- How it works (plain): Breaks down fibrin (clot mesh) in test systems and raises fibrin-breakdown markers after a 2,000 FU dose in small human work. “Dissolves plaque like Drano” is the YouTube sentence, not a settled mechanism. trial
- Dose threshold lore: Low 2,000–3,600 FU studies looked mixed. A 1,062-person Chinese chart-review people paste used ~10,800 FU/day for CIMT/plaque talk. That paper is retrospective, no clean placebo, industry authors — YouTube skeptics hammer this. trial
Stacks
- Solo 2,000 FU first: The cautious start. forum
- + Fish oil / nattokinase in the same “blood flow” drawer (CoffeeBlack stack also had tadalafil, telmisartan, NAC). forum
- + Lumbrokinase: Long-COVID “enzyme stack.” Bleeding worry stacks too. forum
- Not with warfarin/DOAC experiments. Forum consensus is ask a clinician or don’t. trial
Storage notes
- Capsules. No BAC water. Cool, dry. forum
- Enteric-coated bottles exist for the stomach-acid argument. forum
Watch for
- Bleeding / bruising: The real watch-for. Nosebleeds, easy bruise, “thins the blood majorly at 4000 FU” logs. forum
- Low BP: 2,000 FU × 5 days put one r/Supplements user on the floor. anecdote
- Plaque-paper skepticism: 36% reduction from an uncontrolled manufacturer-linked series. forum
- Soy / fermentation allergy. forum
- Additive with anticoagulants / antiplatelets / high-dose fish oil. trial
- Surgery: Pause ~2 weeks is the repeated caution. trial
- Not a clot-busting ER drug. Stroke/MI is a hospital, not a 12k FU cap. trial